US OptionsDetailed Quotes
GRRR241220P15000
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover683.20%IV-69.01%PremiumDec 20, 2024Expiry Date6.13Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5900Delta0.0534Gamma1.18Leverage Ratio-0.2772Theta-0.0016Rho-0.69Eff Leverage0.0041Vega
Gorilla Technology Stock Discussion
Bloomberg TV - Gorilla Technology (14Dec2024, 7pm) video link: https://youtu.be/8oSe8YK1awQ?si=l6N2W7IdcCIrPFF4
Key takeaway:
‐ sound management team
‐ patented technological moats of software & hardware (3 high-growth integrated transformative drivers - AI, cybersecurity&analytics, smart infrastructure&network)
‐ accelerating top and bottom-line growths (revenue and profit growth above 50% annually)
‐ 220% sales growth in 1H2024
‐ planning to start quarterly report...
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
$Checkpoint Therapeutics (CKPT.US)$
$Gorilla Technology (GRRR.US)$ $Fortress Biotech (FBIO.US)$ $Tonix Pharmaceuticals (TNXP.US)$
No comment yet